It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Videolaryngoscopes with an operating channel may improve the intubation success rate in critically ill patients. We aimed to compare four channelled videolaryngoscopes to the Macintosh laryngoscope used for intubation of a high-fidelity simulation mannikin, in a scenario that simulated critical illness due to acute respiratory failure.
Results
Of the 79 residents who participated, 54 were considered inexperienced with orotracheal intubation. Each participant used all five devices in random order. The first-pass success rate was 97.5% [95% CI 91.1–99.7] for Airtraq™, KingVision™, and Pentax AWS200™, 92.4% [95% CI 84.2–97.2] for VividTrac VT-A100™, and 70.9% [95% CI 59.6–80.6] for direct Macintosh laryngoscopy. The first-pass success rate was significantly lower with direct Macintosh laryngoscopy than with the videolaryngoscopes (p < 0.0001 for Airtraq™, KingVision™, Pentax AWS200™, and VividTrac VT-A100™).
Conclusion
The Airtraq™, KingVision™, and Pentax AWS200™ channelled videolaryngoscopes produced high first-pass success rates with a lower boundary of the 95% CI above 90%. A multicentre, randomised controlled clinical study comparing channelled videolaryngoscopy to direct laryngoscopy should include one of these three videolaryngoscopes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Nantes, France (GRID:grid.277151.7) (ISNI:0000 0004 0472 0371)
2 Université de Nantes, CHU Nantes, Pôle Anesthésie-Réanimation, Hôtel Dieu, Service d’Anesthésie Réanimation Chirurgicale, Nantes, France (GRID:grid.4817.a); Laboratoire Expérimental de Simulation de Médecine Intensive de L’Université (LE SiMU) de Nantes, Nantes, France (GRID:grid.4817.a)
3 Centre Hospitalier Universitaire de Nantes, Plateforme de Méthodologie Et Biostatistique, Direction de La Recherche de L’Innovation, Nantes, France (GRID:grid.277151.7) (ISNI:0000 0004 0472 0371)
4 Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Nantes, France (GRID:grid.277151.7) (ISNI:0000 0004 0472 0371); Médecine Intensive Réanimation, Centre Hospitalier Universitaire de Nantes, Nantes, France (GRID:grid.277151.7) (ISNI:0000 0004 0472 0371)